Suchergebnisse - "Yokota, Toshifumi"

PubPharm (211)

1

Duchenne muscular dystrophy : promising early-stage clinical trials to watch

enthalten in: Expert opinion on investigational drugs | 2024

von Tang, A. | Yokota, T.

2

The Dysferlinopathies Conundrum : Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments

enthalten in: Biomolecules | 2024

von Anwar, S. | Yokota, T.

3

Antisense oligonucleotides that bind to exon 51 of human dystrophin pre-mRNA

enthalten in: Europäisches Patentamt | 2024

von YOKOTA TOSHIFUMI | ECHIGOYA YUSUKE

4

Antisense oligonucleotides that bind to exon 51 of human dystrophin pre-mRNA

enthalten in: Europäisches Patentamt | 2024

von YOKOTA TOSHIFUMI | ECHIGOYA YUSUKE

5

Safety concerns surrounding AAV and CRISPR therapies in neuromuscular treatment

enthalten in: Med (New York, N.Y.) | 2023

von Wilton-Clark, H. | Yokota, T.

6

Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva : From Current Paradigms to Therapeutic Frontiers

enthalten in: Genes | 2023

von Anwar, S. | Yokota, T.

7

Enhancing Antisense Oligonucleotide-Based Therapeutic Delivery with DG9, a Versatile Cell-Penetrating Peptide

enthalten in: Cells | 2023

von Haque, U. | Yokota, T.

8

CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

enthalten in: Molecular therapy. Methods & clinical development | 2023

von Wilton-Clark, H. | Yokota, T.

9

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy (SBMA): Focus on Prevalence in the Indigenous Population of Western Canada

enthalten in: Preprints.org | 2023

von Wilton-Clark, H. | Al-aghbari, A. | Yang, J. | +1

10

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy : Focus on Prevalence in the Indigenous Population of Western Canada

enthalten in: Genes | 2023

von Wilton-Clark, H. | Al-Aghbari, A. | Yang, J. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]